vimarsana.com
  1. Home
  2. Live Updates
  3. Roserm Mental Health - Breaking News

Latest Breaking News On - Roserm mental health - Page 1 : vimarsana.com

FDA Approves Otsuka and Lundbeck s ABILIFY ASIMTUFII® (aripiprazole), the First Once-Every-Two-Months Long-acting Injectable (LAI) for the Treatment of Schizophrenia or Maintenance Monotherapy Treatment of Bipolar I Disorder in Adults | Illinois

PRINCETON, N.J. & DEERFIELD, Ill. (BUSINESS WIRE) Apr 27, 2023

United statesNordrhein westfalenJohn krausJohan luthmanStatesjeffrey gilbertStatesdyana lescohierStatesrobert murphyOtsuka america pharmaceutical incAmerican psychiatric associationOtsuka pharmaceutical development commercialization incCo ltdOtsuka pharmaceutical co ltdOtsuka holdings co ltdDrug administrationH lundbeckOtsuka pharmaceutical company ltd

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.